| Media Industry | Communication Services Sector | - CEO | KRX SM Exchange | - ISIN |
| South Korea Country | 48 Employees | - Last Dividend | 14 Apr 2025 Last Split | - IPO Date |
MiCo BioMed Co., Ltd., formerly known as MiCo NanoBioSys Co., Ltd. until March 2018, stands at the forefront of on-site diagnostic technology through its innovative Lab-on-a-Chip systems. Established in 2009, the company is headquartered in Seongnam-si, South Korea. It specializes in the development and manufacturing of molecular diagnostics devices, biological chemistry products, and immunodiagnostics products, catering to the need for rapid and reliable diagnostic solutions across the healthcare industry.